UroGen Pharma Ltd. (URGN)
21.80
-0.56
(-2.50%)
USD |
NASDAQ |
Dec 12, 16:00
21.79
-0.01
(-0.05%)
After-Hours: 20:00
UroGen Pharma Market Cap: 1.020B for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.54B |
| MeiraGTx Holdings Plc | 717.98M |
| CEL-SCI Corp. | 19.30M |
| AIM ImmunoTech, Inc. | 1.047M |
| IGC Pharma, Inc. | 32.29M |
Market Cap Related Metrics
| PS Ratio | 10.74 |
| PEG Ratio | -0.6204 |
| Price | 21.80 |
| Earnings Yield | -15.88% |
| PEGY Ratio | -0.6204 |